Demir Kubilay, Boutros Michael
Division of Signaling and Functional Genomics, Department for Cell and Molecular Biology, German Cancer Research Center (DKFZ), Heidelberg University, Heidelberg, Germany.
Methods Mol Biol. 2012;910:1-13. doi: 10.1007/978-1-61779-965-5_1.
Over the last decade, cell-based screening has become a powerful method in target identification and plays an important role both in basic research and drug discovery. The availability of whole genome sequences and improvements in cell-based screening techniques opened new avenues for high-throughput experiments. Large libraries of RNA interference reagents available for many organisms allow the dissection of broad spectrum of cellular processes. Here, we describe the current state of the large-scale phenotype screening with a focus on cell-based screens. We underline the importance and provide details of screen design, scalability, performance, data analysis, and hit prioritization. Similar to classical high-throughput in vitro screens with defined-target approaches in the past, cell-based screens depend on a successful establishment of robust phenotypic assays, the ability to quantitatively measure phenotypic changes and bioinformatics methods for data analysis, integration, and interpretation.
在过去十年中,基于细胞的筛选已成为靶点识别的一种强大方法,在基础研究和药物发现中都发挥着重要作用。全基因组序列的可得性以及基于细胞的筛选技术的改进为高通量实验开辟了新途径。适用于多种生物体的大量RNA干扰试剂库使得对广泛的细胞过程进行剖析成为可能。在此,我们描述大规模表型筛选的现状,重点是基于细胞的筛选。我们强调其重要性,并提供筛选设计、可扩展性、性能、数据分析和命中优先级排序的详细信息。与过去采用明确靶点方法的经典高通量体外筛选类似,基于细胞的筛选依赖于成功建立稳健的表型分析方法、定量测量表型变化的能力以及用于数据分析、整合和解释的生物信息学方法。